Weeks after human milk recall, no clarity on product test in India | India News


More than three weeks after the recall of human milk products sold by Neokare, a sister concern of the for-profit company Neolacta that sells human milk in India, it is unclear whether the same products being sold here have undergone independent testing by any regulatory agency in India, though the company maintains they have been tested and sound safe.
On January 6, the Food Standards Agency of the UK notified that a small number of breast milk products were being recalled for containing “elevated lead levels”. It said that it was working with the company Neokare Nutrition Ltd to investigate how breast milk products made by the company contained elevated lead levels. It also stated: “There are no maximum levels for lead set in legislation for human breast milk. However, NeoKare Nutrition Limited’s Mother’s Milk Fortifier product is also classed as ‘food for special medical purposes’, which has to be given under medical supervision, and this product does have a maximum legal limit for lead.” Since these products are given to preterm babies, there was great concern though the risk was deemed to be low as it is unlikely to have led to prolonged exposure.
When contacted, Saurabh Aggarwal, founder and managing director of Neolacta stated: “Neokare Nutrition UK and NeoLacta Lifesciences India are two separate entities and work independently. Neokare Nutrition UK uses processing equipment with independent operations on milk collection/processing as per global standards and regulatory requirements. We work very closely with the regulatory authorities in the UK and the technical glitch of an equipment has been sorted post due diligence with the regulatory authorities in UK.”
He added that the products supplied in India, have been duly tested for lead content by labs approved by both Food Safety and Standards Authority of India (FSSAI) & the Ayush ministry. The tests results are well within the prescribed limits and there is no incidence of deviation from set standards. He also clarified that there was no export of milk from Neolacta Lifesciences India to any country and that all supplies were only made within India.
Neolacta sells mother’s milk and products made from it using an Ayush licence issued by the state Ayush licensing authority after the Food Safety and Standards Authority of India cancelled its licence in 2021. The Ayush licensing authority tried to cancel the licence after the government of India through the health ministry stated in Parliament that commercialisation of human breast milk was not allowed in India. However, Neolacta continues to process and sell human milk after getting a stay on the cancellation of the licence from the Karnataka high court.
Since it operates under an Ayush licence, TOI had sent queries to the Ayush ministry asking if the Ayush licensing authorities had lifted samples of the Neolacta products being sold in India and tested them. There has been no response from the ministry. Neither Food Safety and Standards Authority of India nor the health ministry have responded to queries regarding safeguards and processes followed in India if there is concern that a product sold here might be dangerous and adulterated, after an alert and recall of a similar product in another country.

#Weeks #human #milk #recall #clarity #product #test #India #India #News

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button